Related Experiment Video
Updated: May 3, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by
M G Mathieu1, A K Miles1, M Ahmad1
1The John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham, UK.
Abstract:
The tumour suppressor PML (promyelocytic leukaemia protein) regulates several cellular pathways involving cell growth, apoptosis, differentiation and senescence. PML also has an important role in the regulation of stem cell proliferation and differentiation. Here, we show the involvement of the helicase HAGE in the transcriptional repression of PML expression in ABCB5+ malignant melanoma-initiating cells (ABCB5+ MMICs), a population of cancer stem cells which are responsible for melanoma growth, progression and resistance to drug-based therapy. HAGE prevents PML gene expression by inhibiting the activation of the JAK-STAT (janus kinase-signal transducers and activators of transcription) pathway in a mechanism which implicates the suppressor of cytokine signalling 1 (SOCS1). Knockdown of HAGE led to a significant decrease in SOCS1 protein expression, activation of the JAK-STAT signalling cascade and a consequent increase of PML expression. To confirm that the reduction in SOCS1 expression was dependent on the HAGE helicase activity, we showed that SOCS1, effectively silenced by small interfering RNA, could be rescued by re-introduction of HAGE into cells lacking HAGE. Furthermore, we provide a mechanism by which HAGE promotes SOCS1 mRNA unwinding and protein expression in vitro. Finally, using a stem cell proliferation assay and tumour xenotransplantation assay in non-obese diabetic/severe combined immunodeficiency mice, we show that HAGE promotes MMICs-dependent tumour initiation and tumour growth by preventing the anti-proliferative effects of interferon-α (IFNα). Our results suggest that the helicase HAGE has a key role in the resistance of ABCB5+ MMICs to IFNα treatment and that cancer therapies targeting HAGE may have broad implications for the treatment of malignant melanoma.
Insights
The helicase HAGE suppresses promyelocytic leukaemia protein (PML) expression in melanoma stem cells by inhibiting the JAK-STAT pathway. Targeting HAGE may overcome resistance to interferon-α (IFNα) therapy in malignant melanoma.
Area of Science:
- Molecular Biology
- Cancer Stem Cell Biology
- Melanoma Research
Background:
- The tumour suppressor PML regulates key cellular processes including growth, apoptosis, and stem cell differentiation.
- Cancer stem cells, such as ABCB5+ malignant melanoma-initiating cells (MMICs), drive melanoma growth and treatment resistance.
- The helicase HAGE's role in regulating PML expression within MMICs is not well understood.
Purpose of the Study:
- To investigate the role of the helicase HAGE in regulating PML expression in ABCB5+ MMICs.
- To elucidate the molecular mechanism by which HAGE affects PML expression and its impact on melanoma stem cell function.
- To assess the therapeutic potential of targeting HAGE in malignant melanoma.
Main Methods:
- Investigated HAGE's effect on PML gene expression in ABCB5+ MMICs.
- Utilized knockdown and rescue experiments to assess HAGE's role in the JAK-STAT signaling pathway and SOCS1 expression.
- Performed in vitro mRNA unwinding assays to determine HAGE's mechanism of action on SOCS1.
- Conducted stem cell proliferation and mouse xenotransplantation assays to evaluate HAGE's impact on tumor initiation and growth.
Main Results:
- HAGE was found to transcriptionally repress PML expression in ABCB5+ MMICs by inhibiting the JAK-STAT pathway via SOCS1.
- Knockdown of HAGE decreased SOCS1, activated JAK-STAT signaling, and increased PML expression.
- HAGE's helicase activity was essential for suppressing SOCS1 expression and promoting MMIC proliferation.
- HAGE promotes MMIC-dependent tumor initiation and growth by counteracting the anti-proliferative effects of interferon-α (IFNα).
Conclusions:
- The helicase HAGE plays a critical role in maintaining the stemness and proliferation of malignant melanoma-initiating cells.
- HAGE contributes to resistance against interferon-α (IFNα) therapy in melanoma by repressing PML expression.
- Targeting HAGE represents a potential therapeutic strategy to overcome treatment resistance in malignant melanoma.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
The Intrinsic Apoptotic Pathway
Regulation of Hematopoietic Stem Cells
Mechanisms of Retrovirus-induced Cancers
Hedgehog Signaling Pathway

